Insider Cluster (2 insiders) ·Filed Aug 3, 2026

PGEN

PRECIGEN, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago
Insider cluster: 2 insiders, $826K total
Actionable Insight • Neutral

Insider sales are trivial relative to market cap and consistent with routine vesting/liquidity. No bearish signal. Monitor for any material corporate events (earnings, pipeline updates) that could change the outlook, but this cluster alone does not warrant action.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
PGEN ▲ +5.05% at T+20d
NEUTRAL call ✓ call won +5.05% · α vs SPY +6.29% · entry $6.53 → $6.86
Next anchor: T+60d in 25d
Latest observation: T+39 -0.21% FF3 residual α
Entry anchored
Aug 3, 03:59 PM ET
via exchange tick
T+1d
+5.51%
call +5.51% · α +5.71%
$6.89
settled 8w ago
T+5d
+5.05%
call +5.05% · α +5.15%
$6.86
settled 8w ago
T+20d
+5.05%
call +5.05% · α +6.29%
$6.86
settled 5w ago
T+60d
—
call — · α —
—
in 25d

Price Chart

Loading chart...

Executive Summary

Precigen insiders (CFO and COO) sold a combined $826K in open-market sales over a 4-day window. The CFO sold $606K at $6.06, and the COO sold $220K at $6.50 after exercising derivatives. At a $2.2B market cap, these sales represent ~0.04% of market cap — well below the 0.1% materiality threshold — and are likely routine liquidity/vesting-related sales rather than a bearish signal. The cluster is not amplified by the proportionality band, and the COO's sale directly follows a derivative exercise (same-day same-share-count), confirming a tax/vesting pattern. No bearish read-through warranted.

Key Financial Metrics

Direction
selling
Total Value
$826.0K
Insiders
2

Key Facts

  • CFO Thomasian sold 100,000 shares at $6.06 for $606K on 2026-07-31
  • COO Shah sold 33,772 shares at $6.50 for $220K on 2026-08-03, following a same-day derivative exercise of 33,772 shares at $0
  • COO also exercised 33,772 shares at $2.33 for $78,689 on 2026-08-03 (non-cash exercise)
  • Total open-market sales: $826K, representing ~0.04% of $2.2B market cap
  • No open-market purchases in the cluster

Financial Impact

Total insider sales of $826K, negligible relative to $2.2B market cap (0.04%)

insider_ownership

Risk Factors

  • Insider sales could accelerate if stock price rises further
  • No purchases to signal conviction from management

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
78% bullish (9 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-PGEN-1785795196323
12 reports for PGEN
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+60▲ +52.17%May 13, 2026
Filters
Rows
Reports for PGEN — sortable, filterable
TypeNow
Aug 29, 2026
4w ago
Insider Cluster
NEUTRAL ★ 3/10
$6.93 $7.94▲ +14.57%▲ +14.51%$8.30 (+19.70%)
Aug 26, 2026
5w ago
144
NEUTRAL ★ 3/10
$7.19 $7.70▲ +7.09%▲ +7.60%$8.30 (+15.37%)
Aug 25, 2026
5w ago
Insider Cluster
BEARISH ★ 4/10
$7.42 $7.70▼ −3.77%▼ −3.55%$8.30 (−11.79%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$7.42 $7.70▲ +3.77%▲ +3.55%$8.30 (+11.79%)
Aug 7, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$7.00 $6.87▼ −1.86%▼ −0.94%$8.30 (+18.50%)
Aug 3, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$6.53 $6.86▲ +5.05%▲ +6.29%$8.30 (+27.03%)
Jul 1, 2026
13w ago
Insider Cluster
BEARISH ★ 5/10
$5.64 $5.94▼ −5.32%▼ −5.73%$8.30 (−47.07%)
Jun 24, 2026
14w ago
8-K
NEUTRAL ★ 3/10
$5.52 $5.54▲ +0.36%▼ −0.17%$8.30 (+50.27%)
Jun 1, 2026
17w ago
Insider Cluster
NEUTRAL ★ 3/10
$3.86 $5.25▲ +36.01%▲ +37.58%$8.30 (+114.90%)
Jun 1, 2026
17w ago
Insider Cluster
NEUTRAL ★ 3/10
$3.86 $5.25▲ +36.01%▲ +37.58%$8.30 (+114.90%)
Showing 10 of 12

US Market Status

Market Open — Closes in 3h 41m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 3, 2026